Galanin and spinal nociceptive mechanisms:: recent advances and therapeutic implications

被引:81
作者
Xu, XJ
Hökfelt, T
Bartfai, T
Wiesenfeld-Hallin, Z
机构
[1] Karolinska Inst, Div Clin Neurophysiol, Dept Med Lab Sci & Technol, Huddinge, Sweden
[2] Karolinska Inst, Dept Neurosci, Div Chem Neurotransmiss, Stockholm, Sweden
[3] Harold L Norris Neurol Res Ctr, Dept Pharmacol, La Jolla, CA USA
关键词
D O I
10.1054/npep.2000.0820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Galanin is a peptide consisting of 29 or 30 (in humans) amino acids that is present in sensory and spinal dorsal horn neurons. Endogenous galanin may have an important modulatory function on nociceptive input at the spinal level. In addition, exogenously administered galanin exerts complex effects on spinal nociceptive transmission, where inhibitory action appears to predominate. Peripheral nerve injury and inflammation, conditions associated with chronic pain, upregulate the synthesis of galanin in sensory neurons and spinal cord neurons, respectively. Hence, the sensory effect of galanin may be increased under these conditions, raising the possibility that modulation of the activity of the galanin system may produce antinociception. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 97 条
[1]   GALANIN-RECEPTOR LIGAND M40 PEPTIDE DISTINGUISHES BETWEEN PUTATIVE GALANIN-RECEPTOR SUBTYPES [J].
BARTFAI, T ;
LANGEL, U ;
BEDECS, K ;
ANDELL, S ;
LAND, T ;
GREGERSEN, S ;
AHREN, B ;
GIROTTI, P ;
CONSOLO, S ;
CORWIN, R ;
CRAWLEY, J ;
XU, XJ ;
WIESENFELDHALLIN, Z ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11287-11291
[2]   M-15 - HIGH-AFFINITY CHIMERIC PEPTIDE THAT BLOCKS THE NEURONAL ACTIONS OF GALANIN IN THE HIPPOCAMPUS, LOCUS-CERULEUS, AND SPINAL-CORD [J].
BARTFAI, T ;
BEDECS, K ;
LAND, T ;
LANGEL, U ;
BERTORELLI, R ;
GIROTTI, P ;
CONSOLO, S ;
XU, XJ ;
WIESENFELDHALLIN, Z ;
NILSSON, S ;
PIERIBONE, VA ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10961-10965
[3]  
BARTFAI T, 1993, CRIT REV NEUROBIOL, V7, P229
[4]   GALANIN RECEPTORS AND THEIR 2ND MESSENGERS IN THE LUMBAR DORSAL SPINAL-CORD [J].
BEDECS, K ;
LANGEL, U ;
BARTFAI, T ;
WIESENFELDHALLIN, Z .
ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 144 (03) :213-220
[5]   Galanin receptor subtypes [J].
Branchek, TA ;
Smith, KE ;
Gerald, C ;
Walker, MW .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :109-116
[6]  
Calza L, 1998, NEUROSCIENCE, V82, P575
[7]   DISTRIBUTION OF GALANIN IMMUNOREACTIVITY IN THE CENTRAL NERVOUS-SYSTEM AND THE RESPONSES OF GALANIN-CONTAINING NEURONAL PATHWAYS TO INJURY [J].
CHNG, JLC ;
CHRISTOFIDES, ND ;
ANAND, P ;
GIBSON, SJ ;
ALLEN, YS ;
SU, HC ;
TATEMOTO, K ;
MORRISON, JFB ;
POLAK, JM ;
BLOOM, SR .
NEUROSCIENCE, 1985, 16 (02) :343-354
[8]   The effect of a peripheral mononeuropathy on immunoreactive (ir)-galanin release in the spinal cord of the rat [J].
Colvin, LA ;
Mark, MA ;
Duggan, AW .
BRAIN RESEARCH, 1997, 766 (1-2) :259-261
[9]   Primary afferent-evoked release of immunoreactive galanin in the spinal cord of the neuropathic rat [J].
Colvin, LA ;
Duggan, AW .
BRITISH JOURNAL OF ANAESTHESIA, 1998, 81 (03) :436-443
[10]   NGF and LIF both regulate galanin gene expression in primary DRG cultures [J].
Corness, J ;
Stevens, B ;
Fields, RD ;
Hokfelt, T .
NEUROREPORT, 1998, 9 (07) :1533-1536